Titan Biotech board approves 1:4 bonus issue and Rs 0.50 dividend

Corporate Actions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹414.85

prior close

₹435.55

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.6%+4.4% vs market

Specialty Chemicals peers, median of 102sector+0.6%+4.4% vs sector

On the reaction day the stock moved 4.4 pts more than Nifty Microcap 250 and 4.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.0+0.6+4.4+0.6+4.4

Next day

+5.6+1.3+4.3+0.5+5.0

+0.0+1.7-1.7+0.8-0.7

-2.6+2.2-4.9+1.1-3.7

+1.3+2.1-0.8+1.2+0.1

+5.3+1.9+3.5+1.1+4.2

+0.4-1.3+1.7-2.3+2.6

15d

-4.5+1.3-5.9+0.8-5.4

-7.5-0.8-6.7-2.2-5.3

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 102Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Titan Biotech board on Sep 3, 2026 approved bonus shares in 1:4 ratio (1 free share for every 4 held), totaling about 1.03 crore new shares. Also recommended final dividend of Rs 0.50 per share. Record date fixed as Sep 22, 2026. AGM on Sep 29, 2026. Free reserves of about Rs 16,257.78 lakhs available for capitalization. Bonus shares to be credited by Nov 3, 2026, subject to shareholder approval.

Likely market impact

Positive for shareholders. Share count rises 25 percent via bonus plus Rs 0.50 dividend declared. Subject to AGM approval.